Company / EPS (Diluted)
GRAIL, Inc. EPS (Diluted) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$47.21
FY2025
5-year range
-$173.89 / -$47.21
FY2022-FY2025
Trend
+72.9%
vs FY2024
Sector context
#159 of 159
Health Care
What the data says
Among 159 Health Care companies, GRAIL, Inc. is in the bottom 0% for eps (diluted).
Based on SEC 10-K filings.
-47.21 in FY2025.
Remained stable around $-47.21 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 159This company -$47.21 Sector average $1.56
▼
-3132.8% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 72.9% year-over-year.
- Ranks #159 out of 159 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$47.21 | +72.9% |
| FY2024 | -$173.89 | -268.3% |
| FY2023 | -$47.21 | +72.9% |
| FY2022 | -$173.89 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026